ERYTECH PHARMA (ERYP.PA) Stock Analyst Ratings
Europe - EPA:ERYP - FR0011471135 - Common Stock
0.801 EUR
+0 (+0.25%)
ChartMill assigns a Buy % Consensus number of 42% to ERYP.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.67. This target is 358.43% above the current price.
ERYP.PA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about ERYP.PA.
In the previous month the buy percentage consensus was at a similar level.
ERYP.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
ERYTECH PHARMA / ERYP.PA FAQ
What is the average price target for ERYTECH PHARMA (ERYP.PA) stock?
9 analysts have analysed ERYP.PA and the average price target is 3.67 EUR. This implies a price increase of 358.43% is expected in the next year compared to the current price of 0.801.
How do analysts rate ERYTECH PHARMA (ERYP.PA)?
The consensus rating for ERYTECH PHARMA (ERYP.PA) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover ERYTECH PHARMA (ERYP.PA) stock?
The number of analysts covering ERYTECH PHARMA (ERYP.PA) is 9.